Price
Frequently asked questions
What is Grail's market capitalization?
What is the Earnings Per Share (EPS) for Grail?
What is Grail's revenue over the trailing twelve months?
What is the EBITDA for Grail?
What is the free cash flow of Grail?
How many employees does Grail have, and what sector and industry does it belong to?
What is the free float of Grail's shares?
Financials
Market Cap
$422.89MEPS (TTM)
-$99.94Free Float
26.46MRevenue (TTM)
$109.74MEBITDA (TTM)
-$655.90MFree Cashflow (TTM)
-$676.39MPricing
Information
GRAIL, Inc., formerly GRAIL, LLC, is a healthcare company, which is engaged in saving lives and shifting the paradigm in early cancer detection. It is focused on alleviating the global burden of cancer by using next-generation sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its products include Galleri and Beyond. The Galleri test is a commercially available screening test for early detection of multiple types of cancer, which is termed multi-cancer early detection (MCED). Galleri screening test results can help guide next steps for a diagnosis of cancer by healthcare providers.
1,370
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker